NSAID-ERD and disease burden among patients with chronic rhinosinusitis with nasal polyps in the AROMA registry
Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S312-S313
DOI: 10.1055/s-0044-1785055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Achim Georg Beule und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting non-steroidal anti-inflammatory−exacerbated respiratory disease (NSAID-ERD) have more severe CRSwNP and lower quality of life. This study characterizes CRSwNP patients with NSAID-ERD initiating dupilumab in real-world practice.
Methods
AROMA (NCT04959448) is a prospective global registry, recruiting adults with CRSwNP initiating dupilumab. Quality of life assessments included the 22-item Sino-Nasal Outcome Test (SNOT-22; range 0–110) and total symptom score (TSS; 0–9).
Results
As of February 2023, the study had recruited 303 patients (mean [SD] SNOT-22 and TSS of 45.4 [22.2] and 5.4 [2.3], respectively). Among patients self-reporting history of NSAID-ERD (n=78), scores were 46.5 (21.5) and 5.7 (2.2), respectively. Mean (SD) age at NSAID-ERD diagnosis was 39.3 (11.8) years. Of the patients with previous surgery (n=187), 51 (27.3%) had NSAID-ERD. Among all patients with NSAID-ERD, 11 (14.1%) had undergone confirmatory aspirin challenge, 11 (14.1%) aspirin desensitization, and 15 (19.2%) reported adverse reaction to alcohol consumption.
Conclusion
A quarter of adults with CRSwNP initiating dupilumab in AROMA report having NSAID-ERD, many with high disease burden. However, most have not undergone aspirin challenge or desensitization to confirm their diagnosis. Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Beule, A. G., Desrosiers, M., Laidlaw, T. M., White, A. A., & Corso, E. D. (2024). NSAID-ERD and disease burden among patients with chronic rhinosinusitis with nasal polyps in the AROMA registry. Laryngo-Rhino-Otologie, 103(S 02 S 02), S312-S313. https://doi.org/10.1055/s-0044-1785055
Vancouver
Beule AG, Desrosiers M, Laidlaw TM, White AA, Corso ED. NSAID-ERD and disease burden among patients with chronic rhinosinusitis with nasal polyps in the AROMA registry. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S312-S313. doi:10.1055/s-0044-1785055
BibTeX
@article{Beule2024,
author = {Beule, Achim Georg and Desrosiers, Martin and Laidlaw, Tanya M. and White, Andrew A. and Corso, Eugenio De},
title = {NSAID-ERD and disease burden among patients with chronic rhinosinusitis with nasal polyps in the AROMA registry},
journal = {Laryngo-Rhino-Otologie},
year = {2024},
volume = {103},
number = {S 02 S 02},
pages = {S312--S313},
doi = {10.1055/s-0044-1785055}
}
EUVIMED